ITCI
Intra-Cellular Therapies Inc
Price:  
84.55 
USD
Volume:  
275,834.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI Relative Valuation

-124.0%
Upside

As of 2024-12-09, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (20.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 84.55 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -124.0%.

The range of the Relative Valuation is (14.53) - (22.60) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.8x - 27.9x 24.5x
Forward P/E multiples 17.8x - 27.7x 25.4x
Fair Price (14.53) - (22.60) (20.33)
Upside -117.2% - -126.7% -124.0%
84.55 USD
Stock Price
(20.33) USD
Fair Price

ITCI Relative Valuation - Historical P/E Data

Date P/E
2024-12-03 -104.72
2024-12-02 -105.60
2024-11-29 -105.14
2024-11-27 -106.29
2024-11-26 -106.09
2024-11-25 -104.33
2024-11-22 -105.19
2024-11-21 -104.89
2024-11-20 -105.12
2024-11-19 -102.31
2024-11-18 -101.23
2024-11-15 -102.40
2024-11-14 -107.57
2024-11-13 -108.29
2024-11-12 -108.62
2024-11-11 -112.40
2024-11-08 -112.06
2024-11-07 -111.10
2024-11-06 -109.79
2024-11-05 -109.54
2024-11-04 -105.77
2024-11-01 -106.23
2024-10-31 -104.03
2024-10-30 -104.92
2024-10-29 -94.21
2024-10-28 -94.30
2024-10-25 -93.06
2024-10-24 -92.85
2024-10-23 -92.09
2024-10-22 -94.63
2024-10-21 -94.41
2024-10-18 -96.16
2024-10-17 -96.58
2024-10-16 -93.40
2024-10-15 -91.71
2024-10-14 -90.64
2024-10-11 -93.00
2024-10-10 -90.36
2024-10-09 -89.90
2024-10-08 -88.86
2024-10-07 -87.39
2024-10-04 -89.47
2024-10-03 -88.69
2024-10-02 -89.14
2024-10-01 -89.18
2024-09-30 -89.82
2024-09-27 -89.98
2024-09-26 -89.87
2024-09-25 -91.29
2024-09-24 -92.70